Final ID: HCM22
Sangha Veer, Aminorroaya Arya, Dhingra Lovedeep, Pedroso Aline, Oikonomou Evangelos, Khera Rohan
Aficamten is safe and effective in oHCM with comorbidities obesity, hypertension, and diabetes: a SEQUOIA-HCM sub-studyLee Matthew, Malik Fady, Kupfer Stuart, Wohltman Amy, Coats Caroline, Abraham Theodore, Claggett Brian, Maron Martin, Miao Zi, Meder Benjamin, Olivotto Iacopo, Heitner Stephen, Jacoby Daniel